Seminars in Cancer Biology

Papers
(The H4-Index of Seminars in Cancer Biology is 80. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Editorial Board427
Editorial Board382
Unveiling the role of PIK3R1 in cancer: A comprehensive review of regulatory signaling and therapeutic implications302
Breast cancer metastasis to bone: From epithelial to mesenchymal transition to breast osteoblast-like cells270
Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator242
Small secretory proteins of immune cells can modulate gynecological cancers232
Advances in biology and novel treatments of SCLC211
Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation207
The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting204
Multifaceted role of chemokines in solid tumors: From biology to therapy197
Critical DNA damaging pathways in tumorigenesis194
Dissecting the heritable risk of breast cancer: From statistical methods to susceptibility genes194
Emerging applications of bacteria as antitumor agents190
Targeting Hippo signaling pathway by phytochemicals in cancer therapy189
Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation181
Deregulated transcription factors in the emerging cancer hallmarks176
Editorial Board175
Special issue: Deregulated transcription factors in the cancer therapeutic challenges: An update on cancer stemness features174
Editorial Board174
Gut microbes in gastrointestinal cancers166
Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy164
Association of Chlamydia and Mycoplasma infections with susceptibility to ovarian cancer: A systematic review and meta-analysis163
Erratum to “RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer” [Semin. Cancer Biol. 102–103 (2024) 4–16]162
Targeting micro-environmental pathways by PROTACs as a therapeutic strategy154
Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectives150
Anticancer properties of chimeric HDAC and kinase inhibitors149
PIWI-interacting RNAs in human cancer145
Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse136
Innovative trial design in precision oncology136
Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer132
Enhancing head and neck tumor management with artificial intelligence: Integration and perspectives132
The IL-1 family in tumorigenesis and antitumor immunity129
Origins and molecular effects of hypoxia in cancer125
Genome chaos: Creating new genomic information essential for cancer macroevolution123
Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers123
Molecular targets of tyrosine kinase inhibitors in thyroid cancer123
Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?123
Immune cellular components and signaling pathways in the tumor microenvironment123
New biological and immunological approaches to cancer therapy: Basic and clinical aspects117
Insight into the role of multiple signaling pathways in regulating cancer stem cells of gynecologic cancers114
Reprogramming of glycolysis by chemical carcinogens during tumor development113
Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer113
Cellular stress responses and metabolic reprogramming in cancer progression and dormancy113
Therapy-induced modulation of extracellular vesicles in hepatocellular carcinoma107
Anticancer natural products targeting immune checkpoint protein network106
Editorial Board106
Metabolic landscape and rewiring in normal hematopoiesis, leukemia and aging105
Atrial fibrillation in cancer patients: Epidemiology, identification and management104
Vibrational spectroscopy for decoding cancer microbiota interactions: Current evidence and future perspective103
Targeting the “undruggable”: RNA-binding proteins in the spotlight in cancer therapy103
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools101
Advancement of cancer immunotherapy using nanoparticles-based nanomedicine100
Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems100
How far have we explored fungi to fight cancer?99
Curcumin and colorectal cancer: An update and current perspective on this natural medicine99
Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy99
Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics99
Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors99
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer98
Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics98
Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways97
Editorial Board97
The intricacies of NRF2 regulation in cancer97
Editorial Board97
Cytotoxic activity of l-lysine alpha-oxidase against leukemia cells95
Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications91
The role of RNA processing and regulation in metastatic dormancy91
Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer90
The foundational framework of tumors: Gametogenesis, p53, and cancer89
Role of ubiquitination-driven metabolisms in oncogenesis and cancer therapy89
Metabolic reprogramming of tumor microenviroment by engineered bacteria89
BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer88
Functionalized-DNA nanostructures as potential targeted drug delivery systems for cancer therapy87
Chaperonins in cancer: Expression, function, and migration in extracellular vesicles86
Microbiota and lung cancer85
MITOCHONDRIAL CHOLESTEROL AND CANCER85
Epithelial-mesenchymal transition: Insights into nickel-induced lung diseases85
Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling84
Advancements in small cell lung cancer83
Plant lectins and their usage in preparing targeted nanovaccines for cancer immunotherapy81
Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders80
0.053184986114502